# A Study to Evaluate MWN109 Tablets in Healthy Adult Participants

> **NCT06938269** · PHASE1 · RECRUITING · sponsor: **Shanghai Minwei Biotechnology Co., Ltd** · enrollment: 60 (estimated)

## Conditions studied

- Overweight or Obesity

## Interventions

- **DRUG:** MWN109 tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06938269
- **Lead sponsor:** Shanghai Minwei Biotechnology Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-18
- **Primary completion:** 2026-03
- **Final completion:** 2026-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06938269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06938269, "A Study to Evaluate MWN109 Tablets in Healthy Adult Participants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06938269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*